Back to search
FDAFDA · Food and drugs·Recall number Z-0138-2025

Quantimetrix Urine Chemistry Control Set Dipper Urinalysis Dipstick Testing Levels 1 & 2 6 X 15 mL-IVD intended as a control for urinalysis reagent strips, microalbumin, and creatinine by listed test methods.

Published October 30, 2024 · Recall initiated: September 17, 2024

Summary

FDA records medical device Class II recall Z-0138-2025, published October 30, 2024 and initiated September 17, 2024. Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office; Status: Ongoing; Reported quantity: 1 BOX; Lot: UDI-DI: 896863002134. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The Quantimetrix Dipper Urinalysis Dipstick control was shipped without the validated summer packaging and may have been exposed to temperatures above 25®C. This may lead to delay in patients' results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
US Nationwide distribution in the state of DC.
Lot
UDI-DI: 896863002134
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Quantimetrix Urine Chemistry Control Set Dipper Urinalysis Dipstick Testing Levels 1 & 2 6 X 15 mL-IVD intended as a control for urinalysis reagent strips, microalbumin, and creatinine by listed test methods. recalled?

Yes. FDA published recall Z-0138-2025 on October 30, 2024. Reported hazard: The Quantimetrix Dipper Urinalysis Dipstick control was shipped without the validated summer packaging and may have been exposed to temperatures above 25®C. This may lead to delay in patients' results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter